Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Ribonucleoside in Ataxia Telangiectasia
NCT04870866Phase 2Active, not recruiting
- Start
- Jun 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide riboside in ataxia-telangiectasia (AT). Started Jun 2019; status: active, not recruiting.
02
Drugs
nicotinamide riboside
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on NCT04870866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04870866.